These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 32795924)

  • 1. Syzygium aromaticum (clove) and Thymus zygis (thyme) essential oils increase susceptibility to colistin in the nosocomial pathogens Acinetobacter baumannii and Klebsiella pneumoniae.
    Vázquez-Ucha JC; Martínez-Guitián M; Lasarte-Monterrubio C; Conde-Pérez K; Arca-Suárez J; Álvarez-Fraga L; Pérez A; Crecente-Campo J; Alonso MJ; Bou G; Poza M; Beceiro A
    Biomed Pharmacother; 2020 Oct; 130():110606. PubMed ID: 32795924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro synergy of colistin combinations against colistin-resistant Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae isolates.
    Vidaillac C; Benichou L; Duval RE
    Antimicrob Agents Chemother; 2012 Sep; 56(9):4856-61. PubMed ID: 22751540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic Activity of Niclosamide in Combination With Colistin Against Colistin-Susceptible and Colistin-Resistant
    Ayerbe-Algaba R; Gil-Marqués ML; Jiménez-Mejías ME; Sánchez-Encinales V; Parra-Millán R; Pachón-Ibáñez ME; Pachón J; Smani Y
    Front Cell Infect Microbiol; 2018; 8():348. PubMed ID: 30338245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elucidating the Pharmacokinetics/Pharmacodynamics of Aerosolized Colistin against Multidrug-Resistant Acinetobacter baumannii and Klebsiella pneumoniae in a Mouse Lung Infection Model.
    Lin YW; Zhou QT; Han ML; Chen K; Onufrak NJ; Wang J; Turnidge JD; Howden BP; Forrest A; Chan HK; Li J
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29229637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergy between Colistin and the Signal Peptidase Inhibitor MD3 Is Dependent on the Mechanism of Colistin Resistance in Acinetobacter baumannii.
    Martínez-Guitián M; Vázquez-Ucha JC; Odingo J; Parish T; Poza M; Waite RD; Bou G; Wareham DW; Beceiro A
    Antimicrob Agents Chemother; 2016 Jul; 60(7):4375-9. PubMed ID: 27139471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic activity of
    Ben Selma W; Alibi S; Ferjeni M; Ghezal S; Gallala N; Belghouthi A; Gargouri A; Marzouk M; Boukadida J
    Int J Environ Health Res; 2024 Aug; 34(8):2936-2946. PubMed ID: 37952172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of synergy between sulbactam, meropenem and colistin in carbapenem-resistant Klebsiella pneumoniae and Acinetobacter baumannii isolates and correlation with the molecular mechanism of resistance.
    Laishram S; Anandan S; Devi BY; Elakkiya M; Priyanka B; Bhuvaneshwari T; Peter JV; Subramani K; Balaji V
    J Chemother; 2016 Aug; 28(4):297-303. PubMed ID: 27461479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro synergistic activity of colistin with tigecycline or β-lactam antibiotic/β-lactamase inhibitor combinations against carbapenem-resistant Acinetobacter baumannii.
    Karaoglan I; Zer Y; Bosnak VK; Mete AO; Namiduru M
    J Int Med Res; 2013 Dec; 41(6):1830-7. PubMed ID: 24265334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial synergism and antibiofilm activities of
    Kafa AHT; Aslan R; Celik C; Hasbek M
    Z Naturforsch C J Biosci; 2022 Mar; 77(3-4):95-104. PubMed ID: 34142518
    [No Abstract]   [Full Text] [Related]  

  • 10. Antimicrobial activity of Eucalyptus camaldulensis essential oils and their interactions with conventional antimicrobial agents against multi-drug resistant Acinetobacter baumannii.
    Knezevic P; Aleksic V; Simin N; Svircev E; Petrovic A; Mimica-Dukic N
    J Ethnopharmacol; 2016 Feb; 178():125-36. PubMed ID: 26671210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Vitro Interactions of Antibiotic Combinations of Colistin, Tigecycline, and Doripenem Against Extensively Drug-Resistant and Multidrug-Resistant Acinetobacter baumannii.
    Park GC; Choi JA; Jang SJ; Jeong SH; Kim CM; Choi IS; Kang SH; Park G; Moon DS
    Ann Lab Med; 2016 Mar; 36(2):124-30. PubMed ID: 26709259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
    Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO
    Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of Colistin-Ampicillin/Sulbactam Combination Efficacy in Imipenem-Resistant Acinetobacter baumannii Strains].
    Cıkman A; Ceylan MR; Parlak M; Karahocagil MK; Berktaş M
    Mikrobiyol Bul; 2013 Jan; 47(1):147-51. PubMed ID: 23390912
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Soudeiha MAH; Dahdouh EA; Azar E; Sarkis DK; Daoud Z
    Front Cell Infect Microbiol; 2017; 7():209. PubMed ID: 28596943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic effect of Myrtus communis L. essential oils and conventional antibiotics against multi-drug resistant Acinetobacter baumannii wound isolates.
    Aleksic V; Mimica-Dukic N; Simin N; Nedeljkovic NS; Knezevic P
    Phytomedicine; 2014 Oct; 21(12):1666-74. PubMed ID: 25442275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of Pinus sylvestris L. (Pinaceae), Origanum vulgare L. (Lamiaceae), and Thymus vulgaris L. (Lamiaceae) essential oils and their main components to enhance itraconazole activity against azole susceptible/not-susceptible Cryptococcus neoformans strains.
    Scalas D; Mandras N; Roana J; Tardugno R; Cuffini AM; Ghisetti V; Benvenuti S; Tullio V
    BMC Complement Altern Med; 2018 May; 18(1):143. PubMed ID: 29724221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of Essential Oils Against Multidrug-Resistant Salmonella enteritidis.
    Alibi S; Selma WB; Mansour HB; Navas J
    Curr Microbiol; 2022 Jul; 79(9):273. PubMed ID: 35907084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of colistin plus sulbactam against extensive-drug-resistant Acinetobacter baumannii by checkerboard method.
    Thamlikitkul V; Tiengrim S
    J Med Assoc Thai; 2014 Mar; 97 Suppl 3():S1-6. PubMed ID: 24772574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of the efficacy of colistin/sulbactam combination on carbapenem-resistant Acinetobacter baumannii strains].
    Çetinkol Y; Telli M; Altunçekiç Yıldırım A; Çalgın MK
    Mikrobiyol Bul; 2016 Jul; 50(3):460-5. PubMed ID: 27525401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbapenem and multidrug resistance in Gram-negative bacteria in a single centre in Italy: considerations on in vitro assay of active drugs.
    Mezzatesta ML; Caio C; Gona F; Cormaci R; Salerno I; Zingali T; Denaro C; Gennaro M; Quattrone C; Stefani S
    Int J Antimicrob Agents; 2014 Aug; 44(2):112-6. PubMed ID: 25059444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.